BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

34 related articles for article (PubMed ID: 27788616)

  • 1. Clinical features and prognosis of late-onset neuromyelitis optica spectrum disorders in a Latin American cohort.
    Carnero Contentti E; Daccach Marques V; Soto de Castillo I; Tkachuk V; Ariel B; Castillo MC; Cristiano E; Diégues Serva GB; Dos Santos AC; Finkelsteyn AM; López PA; Patrucco L; Molina O; Pettinicchi JP; Toneguzzo V; Caride A; Rojas JI
    J Neurol; 2020 May; 267(5):1260-1268. PubMed ID: 31932911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuromyelitis optica spectrum disorders.
    Huda S; Whittam D; Bhojak M; Chamberlain J; Noonan C; Jacob A
    Clin Med (Lond); 2019 Mar; 19(2):169-176. PubMed ID: 30872305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics of very late-onset neuromyelitis optica spectrum disorder.
    Cai LJ; Zhang Q; Zhang Y; Chen HX; Shi ZY; Du Q; Zhou HY
    Mult Scler Relat Disord; 2020 Nov; 46():102515. PubMed ID: 33032051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glial autoantibody prevalence in Chinese optic neuritis with onset after age 45: clinical factors for diagnosis.
    Song H; Chuai Y; Yang M; Zhou H; Sun M; Xu Q; Wei S
    Front Immunol; 2023; 14():1181908. PubMed ID: 37705973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical analysis of neuromyelitis optica spectrum disease with area postrema syndrome as the initial symptom.
    Liu T; Li L; Guo X; Li Q; Jia D; Ma L
    Eur J Med Res; 2022 Dec; 27(1):315. PubMed ID: 36582004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age of onset correlates with clinical characteristics and prognostic outcomes in neuromyelitis optica spectrum disorder.
    Hu Y; Sun Q; Yi F; Yao L; Tian Y; Tang H; Luo M; Xie N; Wang Z; Liao X; Zhou L; Xu H; Zhou Y
    Front Immunol; 2022; 13():1056944. PubMed ID: 36569880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relatively Early and Late-Onset Neuromyelitis Optica Spectrum Disorder in Central China: Clinical Characteristics and Prognostic Features.
    Yu J; Yan S; Niu P; Teng J
    Front Neurol; 2022; 13():859276. PubMed ID: 35493805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Early- and Late-Onset NMOSD-Related Optic Neuritis in Thai Patients: Clinical Characteristics and Long-Term Visual Outcomes.
    Thongmee W; Narongkhananukul C; Padungkiatsagul T; Jindahra P; Vanikieti K
    Clin Ophthalmol; 2021; 15():419-429. PubMed ID: 33574650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive Factors of Resistance to High-Dose Steroids Therapy in Acute Attacks of Neuromyelitis Optica Spectrum Disorder.
    Qin C; Tao R; Zhang SQ; Chen B; Chen M; Yu HH; Chu YH; Shang K; Wu LJ; Bu BT; Tian DS
    Front Neurol; 2020; 11():585471. PubMed ID: 33281722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late-onset neuromyelitis optica spectrum disorder: The importance of autoantibody serostatus.
    Sepulveda M; Delgado-García G; Blanco Y; Sola-Valls N; Martinez-Lapiscina EH; Armangué T; Montejo C; Pulido-Valdeolivas I; Martinez-Hernandez E; Ariño H; Escudero D; Ruiz-García R; Llufriu S; Dalmau J; Graus F; Saiz A
    Neurol Neuroimmunol Neuroinflamm; 2019 Nov; 6(6):. PubMed ID: 31471461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics of late-onset neuromyelitis optica spectrum disorder: A multicenter retrospective study in Korea.
    Seok JM; Cho HJ; Ahn SW; Cho EB; Park MS; Joo IS; Shin HY; Kim SY; Kim BJ; Kim JK; Cho JY; Huh SY; Kwon O; Lee KH; Kim BJ; Min JH
    Mult Scler; 2017 Nov; 23(13):1748-1756. PubMed ID: 28058965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of neuromyelitis optica and neuromyelitis optica spectrum disorder patients with a late onset.
    Collongues N; Marignier R; Jacob A; Leite MI; Siva A; Paul F; Zephir H; Akman-Demir G; Elsone L; Jarius S; Papeix C; Mutch K; Saip S; Wildemann B; Kitley J; Karabudak R; Aktas O; Kuscu D; Altintas A; Palace J; Confavreux C; De Seze J
    Mult Scler; 2014 Jul; 20(8):1086-94. PubMed ID: 24323817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Characteristics of Chinese Male Patients with Aquaporin-4 Antibody-Positive Late-Onset Neuromyelitis Optica Spectrum Disorder.
    Liang J; Liu J; Gu M; Zhu C; Xu X; Fan R; Peng F; Jiang Y
    Neuroimmunomodulation; 2021; 28(2):61-67. PubMed ID: 33946074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paraneoplastic neuromyelitis optica spectrum disorders: three new cases and a review of the literature.
    Cai G; He D; Chu L; Dai Q; Xu Z; Zhang Y
    Int J Neurosci; 2016; 126(7):660-8. PubMed ID: 26010208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical concept, etiology and pathology of neuromyelitis optica].
    Kurosawa K; Fujihara K
    Nihon Rinsho; 2014 Nov; 72(11):1897-902. PubMed ID: 25518368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinctive characteristics of early-onset and late-onset neuromyelitis optica spectrum disorders.
    Zhang LJ; Yang LN; Li T; Wang J; Qi Y; Zhang DQ; Yang CS; Yang L
    Int J Neurosci; 2017 Apr; 127(4):334-338. PubMed ID: 27788616
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.